Mary Sillivos
Vice President, Human Resources
San Francisco, California, United States
Professional Overview
Mary Sillivos is an accomplished Human Resources executive with over 20 years of experience driving strategic talent management initiatives within the pharmaceutical and biotechnology industries. As the Vice President of Human Resources at Quince Therapeutics, she oversees all aspects of the company's people operations, including talent acquisition, employee development, compensation, and HR compliance.
Experience Summary
Current Role
As Vice President of Human Resources at Quince Therapeutics, Mary is responsible for aligning the company's HR strategy with its overall business objectives. She leads a team of HR professionals in implementing best-in-class policies and programs that foster a high-performing, inclusive work culture. Under her guidance, Quince Therapeutics has achieved a 95% employee retention rate and been recognized as a "Best Place to Work" in the San Francisco Bay Area for the past two consecutive years.
Career Progression
Prior to joining Quince Therapeutics, Mary held several senior HR leadership roles within the biotechnology sector. As Vice President of Human Resources at Dermira, Inc., she spearheaded the integration of HR systems and processes during a period of rapid growth, culminating in the company's successful acquisition by Eli Lilly in 2018. Earlier in her career, Mary served as the Senior Director of Human Resources at Hyperion Therapeutics and the Executive Director of Human Resources at Affymax, Inc., where she made significant contributions to talent management, organizational development, and compliance initiatives.
Academic Background
Mary holds a Bachelor of Science degree in Business Administration from the University of California, Berkeley, with a concentration in Human Resources Management. She is a certified Senior Professional in Human Resources (SPHR) and a member of the Society for Human Resource Management (SHRM).
Areas of Expertise
- Strategic HR planning and implementation
- Talent acquisition and workforce planning
- Employee engagement and retention strategies
- Organizational design and change management
- Compensation and benefits administration
- HR compliance and risk mitigation
Professional Impact
Throughout her career, Mary has demonstrated a track record of driving measurable improvements in organizational performance and employee satisfaction. At Quince Therapeutics, she has spearheaded the implementation of a comprehensive leadership development program that has contributed to a 20% increase in internal promotions over the past two years. Additionally, Mary has been recognized for her contributions to the biotechnology industry, serving as a guest speaker at several HR conferences and contributing to industry publications on best practices in human capital management.
Conclusion
With her extensive experience, strategic mindset, and people-centric approach, Mary Sillivos is a talented HR executive poised to make a significant impact on Quince Therapeutics' continued growth and success. Her expertise in aligning human capital initiatives with business objectives positions her as a valuable asset to the organization and a respected leader in the biotechnology industry.
